Everolimus (Afinitor®) Clinical Trials
2 recruitingDrug
Phase 31Phase 21
Showing 1–2 of 2 trials
Recruiting
Phase 3
A Study of SIM0270 Combined With Everolimus vs. Treatment of Physician's Choice in Patients With ER+/HER2- Advanced Breast Cancer (SIMRISE)
Locally Advanced or Metastatic Breast Cancer
Jiangsu Simcere Pharmaceutical Co., Ltd.460 enrolled60 locationsNCT06680921
Recruiting
Phase 2
Everolimus and/or Exercise to Prevent Bone Loss in Postmenopausal Women
Postmenopausal Women
Odense University Hospital136 enrolled2 locationsNCT06789900